TP53 and type 2 diabetes mellitus: The first evidence linking p53 to the development of type 2 diabetes was shown by Minamino et al. They demonstrated that inhibition of p53 activity in adipose tissue decreased the expression of proinflammatory cytokines and improved insulin resistance in mice with type 2 diabetes-like disease22.